skip to main content
Idioma:
Primo Search
Clear Search Box
Search in: Busca Geral
Busca Avançada
Busca por Índices

Advanced Cancer Cases Treated With Cultivated Wild Ginseng Phamacopuncture

Lee, Jong-Hoon ; Kwon, Ki-Rok ; Cho, Chong-Kwan ; Han, Sung Soo R. ; Yoo, Hwa-Seung

Journal of Acupuncture & Meridian Studies, 2010, 3(2), 8, pp.119-124 [Periódico revisado por pares]

Korea (South): 사단법인약침학회

Texto completo disponível

Citações Citado por
  • Título:
    Advanced Cancer Cases Treated With Cultivated Wild Ginseng Phamacopuncture
  • Autor: Lee, Jong-Hoon ; Kwon, Ki-Rok ; Cho, Chong-Kwan ; Han, Sung Soo R. ; Yoo, Hwa-Seung
  • Assuntos: Antineoplastic Agents, Phytogenic - administration & dosage ; complementary and alternative medicine ; Drugs, Chinese Herbal - administration & dosage ; Female ; Humans ; Male ; Middle Aged ; Neoplasms - drug therapy ; Neoplasms - mortality ; Neoplasms - pathology ; Panax - chemistry ; Prospective Studies ; quality of life ; response ; stable disease ; Survival Rate ; Treatment Outcome ; wild ginseng pharmacopuncture ; 한의학
  • É parte de: Journal of Acupuncture & Meridian Studies, 2010, 3(2), 8, pp.119-124
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
    G704-SER000001580.2010.3.2.004
  • Descrição: After administering cultivated wild ginseng pharmacopuncture (CWGP) to advanced cancer patients, the response and survival rate were evaluated. This prospective observational pilot study of CWGP was conducted at the East-West Cancer Center of Daejeon University, Dunsan Oriental Hospital from August 2007 to June 2008. Seven patients were recruited for this study. One cycle of treatment consisted of intravenous infusion of CWGP (20 mL/day) for 2 weeks with an expected treatment duration of four cycles (60 days, 2 months). Blood tests were conducted every cycle and computed tomography was performed every second cycle as follow-up. Overall survival was measured from initial administration of CWGP to death. We used the international standards provided by the Response Evaluation Criteria in Solid Tumors for measuring response rate and Kaplan-Meier analysis to determine statistical significance. Seven patients received a total of 55 cycles (1 with 1 cycle, 2 with 2 cycles, 1 with 3 cycles, 2 with 13 cycles, 1 with 20 cycles). One-year survival rate was 57.1%, and the median survival time was 544 days. Among these patients, two non-small cell lung carcinoma patients and one advanced gastric adenocarcinoma patient showed stable disease. Two patients dropped out after the first and second cycles of treatment without receiving a new computed tomography scan. Two patients showed progressive disease. Although a further large scale study is necessary, CWGP showed potential as an effective treatment for two non-small cell lung carcinoma patients and one advanced gastric carcinoma patient.
  • Editor: Korea (South): 사단법인약침학회
  • Idioma: Inglês;Coreano
Links
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.